Innofactor Plc           Stock Exchange Release          September 17, 2024 at 6:05 p.m. (EEST) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. Preliminary result of Onni Bidco’s voluntary recommended public cash tender offer for all the shares in Innofactor Plc; The Offeror has decided that it will waive the minimum acceptance condition As announced on July 22, 2024, CapMan Growth Equity Fund III Ky, a fund managed by CapMan Group affiliated companies, (“CapMan Growth”), Sami Ensio, the founder, CEO and member of the Board of Directors of Innofactor...

Strategic Acquisitions Expected to Generate Over $20M in Annual Revenue, Positioning FOXO for Accelerated Growth MINNEAPOLIS, MN, Sept. 17, 2024 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced it has completed the acquisition of the second revenue-generating operation from Rennova Health, Inc. (OTC: RNVA) (“Rennova”).  The Company had previously announced it had entered into two share exchange agreements with Rennova. The first agreement was to acquire the equity in Myrtle Recovery Centers, Inc., Rennova’s behavioral health services subsidiary. Closing of the Myrtle transaction occurred on June 14, 2024. The second agreement was to acquire the equity in Rennova Community Health, Inc. (RCHI), the owner of Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center),...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ECKOH PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree KEYWORDS STUDIOS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree TI Fluid Systems plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...

Contacts Media Contact Investor RelationsAmsterdam +31 20 721 4133 Brussels +32 2 620 15 50 +33 1 70 48 24 17Dublin +39 02 72 42 62 13 Lisbon +351 210 600 614  Milan +39 02 72 42 62 12 Oslo +47 41 69 59 10  Paris +33 1 70 48 24 45      Euronext acquires leading research and market data benchmarking provider Substantive Research Amsterdam, Brussels, Dublin, Lisbon, London, Milan, Oslo and Paris – 17 September 2024 – Euronext today announces that it has acquired 100% of Substantive Research, an industry-leading pioneer providing in-depth transparency on product and pricing comparison for investment research spend, market data and investment research content. Founded in 2015 and headquartered in London, Substantive Research provides research and market data benchmarking to a growing...

Joining Forces to Strengthen Core Business and Pioneer Security InnovationsFTSI and 21st Century AEYE Announce Strategic MergerFrom left to right: Said Bilani, Susan Napier, and Brannon CastleberryMONROVIA, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) — FTSI, a leader in technology solutions for financial institutions, proudly announces its strategic merger with 21st Century AEYE, a cutting-edge fintech focused on AI-driven innovation. This transformative partnership enhances both companies’ capabilities, combining FTSI’s trusted expertise in banking technology and security with 21st Century’s revolutionary AI solutions. The merged company will continue to operate under the FTSI name, upholding the high standards of service and innovation that customers have come to expect. Through this merger, FTSI will strengthen...

Rowe, Hopstetter to Lead Operations, Integration Effort for Roanoke, New River Valley and Lynchburg MarketsTim RoweTim Rowe (Market President for Member One) is a 38-year veteran of Member One and a lifelong Roanoke-area resident, Rowe will lead regional efforts in member services, employee engagement and community involvement.Jean HopstetterJean Hopstetter (Senior Executive Vice President & Merger Integration Executive) will lead regional efforts related to the organization’s integration goals and objectives. This will include the integration of member-facing operations as well as the work of support and administrative staff.ROANOKE, Virginia, Sept. 16, 2024 (GLOBE NEWSWIRE) — Member One, a division of Virginia Credit Union, is pleased to announce its regional leadership team for the combined Roanoke Valley,...

Global Genome Editing Market size was valued at USD 8.99 billion in 2023 to USD 31.15 billion by 2031, growing at a CAGR of 16.80% during the forecast period (2024-2031). WestFord, Sept. 16, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Genome Editing Market will reach a value of USD 31.15 Billion by 2031, with a CAGR of 16.80% during the forecast period (2024-2031). Genome editing has witnessed notable progress in recent years backed by key trends, including a higher focus on therapeutic applications, the growing use of CRISPR technology, and regulatory developments. The market is facing expansion in clinical trials, wherein some are shifting towards commercialization. These trends are aiding the growth of the genome editing market. Besides, the market is also fueled by technological advancements, essentially CRISPR-Cas9...

Strengthens Rare Disease segment as largest driver of future growth, adding approximately $105 million in 2024 revenue on a pro forma basis Adds two durable commercial assets ILUVIEN® and YUTIQ® with significant growth potential, expanding ANI’s foothold in strategic therapeutic area of ophthalmology Anticipated to drive high single-digit to low double-digit accretion in adjusted non-GAAP EPS in 2025 and to be substantially accretive thereafter New capital structure in place, reducing interest expense by approximately $39 million on an annualized basis (1) ANI maintains its 2024 financial guidance for the standalone Company based on continued momentum across Purified Cortrophin® Gel (Cortrophin Gel) and GenericsPRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP)...